BERTOLI, GLORIA RITA
 Distribuzione geografica
Continente #
AS - Asia 1.825
NA - Nord America 1.083
EU - Europa 467
SA - Sud America 305
AF - Africa 43
OC - Oceania 5
Totale 3.728
Nazione #
US - Stati Uniti d'America 1.021
SG - Singapore 694
CN - Cina 474
BR - Brasile 251
IT - Italia 175
HK - Hong Kong 174
VN - Vietnam 174
KR - Corea 106
FR - Francia 85
FI - Finlandia 45
JP - Giappone 44
IN - India 38
GB - Regno Unito 34
NL - Olanda 32
DE - Germania 29
CA - Canada 27
BD - Bangladesh 23
AR - Argentina 19
MX - Messico 19
TR - Turchia 15
EC - Ecuador 12
ID - Indonesia 11
IL - Israele 11
PL - Polonia 9
ZA - Sudafrica 9
CO - Colombia 7
EG - Egitto 7
KZ - Kazakistan 7
PH - Filippine 7
RU - Federazione Russa 7
UZ - Uzbekistan 7
DZ - Algeria 6
KE - Kenya 6
MA - Marocco 6
SE - Svezia 6
IE - Irlanda 5
IQ - Iraq 5
PK - Pakistan 5
UA - Ucraina 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
AT - Austria 4
CZ - Repubblica Ceca 4
ES - Italia 4
JO - Giordania 4
PE - Perù 4
AU - Australia 3
AZ - Azerbaigian 3
CH - Svizzera 3
GR - Grecia 3
JM - Giamaica 3
LV - Lettonia 3
PY - Paraguay 3
SA - Arabia Saudita 3
SN - Senegal 3
TT - Trinidad e Tobago 3
CL - Cile 2
CR - Costa Rica 2
DK - Danimarca 2
HN - Honduras 2
HU - Ungheria 2
KG - Kirghizistan 2
KW - Kuwait 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
OM - Oman 2
PA - Panama 2
PR - Porto Rico 2
PT - Portogallo 2
TH - Thailandia 2
TN - Tunisia 2
AL - Albania 1
BE - Belgio 1
BO - Bolivia 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
GE - Georgia 1
IR - Iran 1
LK - Sri Lanka 1
LT - Lituania 1
MO - Macao, regione amministrativa speciale della Cina 1
MQ - Martinica 1
MY - Malesia 1
NP - Nepal 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
RW - Ruanda 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
ZM - Zambia 1
Totale 3.728
Città #
Singapore 409
Santa Clara 354
Hefei 221
Hong Kong 167
San Jose 119
Seoul 104
Beijing 87
Ashburn 80
Lauterbourg 67
Los Angeles 57
Ho Chi Minh City 56
Dallas 52
Milan 41
Hanoi 35
Tokyo 30
Rome 26
New York 22
Helsinki 21
São Paulo 19
Brescia 17
Buffalo 17
Lappeenranta 17
Da Nang 14
Council Bluffs 12
Minamishinagawa 11
Rio de Janeiro 11
Amsterdam 9
London 9
Orem 9
Warsaw 9
Bengaluru 8
Frankfurt am Main 8
Haiphong 8
Chennai 7
Manchester 7
Toronto 7
Atlanta 6
Belo Horizonte 6
Brasília 6
Brooklyn 6
Guayaquil 6
Phoenix 6
Tashkent 6
Turku 6
Can Tho 5
Dhaka 5
Goiânia 5
Miami 5
Montreal 5
Munich 5
Nairobi 5
Thái Nguyên 5
Albaredo d'Adige 4
Amman 4
Ankara 4
Athens 4
Boardman 4
Cairo 4
Chicago 4
Des Moines 4
Dubai 4
Dublin 4
Guarulhos 4
Ha Long 4
Hải Dương 4
Johannesburg 4
Marseille 4
Mexico City 4
Mumbai 4
Nuremberg 4
Ribeirão Preto 4
San Martino in Rio 4
Stockholm 4
Vienna 4
Algiers 3
Almaty 3
Baku 3
Bogotá 3
Boston 3
Bắc Giang 3
City of London 3
Curitiba 3
Dakar 3
Duque de Caxias 3
Düsseldorf 3
Guadalajara 3
Guangzhou 3
Hortolândia 3
Juiz de Fora 3
Kingston 3
Lang Son 3
Lima 3
Madrid 3
Naples 3
Ninh Bình 3
Porto Alegre 3
Prague 3
Richmond 3
Riga 3
Santo André 3
Totale 2.401
Nome #
Biodiversity and planetary health: a call for integrated action 117
Building the Future of Biodiversity: Italy's National Biodiversity Future Center (NBFC) Initiative 92
Clinical, functional, behavioural and epigenomic biomarkers of obesity 84
Investigating the anti-cancer potential of natural bioactive molecules in triple-negative breast cancer 84
Identification of microRNA clusters cooperatively acting on epithelial to mesenchymal transition in triple negative breast cancer. 79
Theranostic application of miR-429 in HER2+breast cancer 78
A rat mammary gland cancer cell with stem cell properties of self-renewal, multi-lineage differentiation and tumor sustainability 75
A Novel Strategy for Glioblastoma Treatment by Natural Bioactive Molecules Showed a Highly Effective Anti-Cancer Potential 75
The biological interplay between air pollutants and miRNAs regulation in cancer 74
Circulating microRNAs as Potential Novel Diagnostic Biomarkers to Predict Drug Resistance in Temporal Lobe Epilepsy: A Pilot Study 72
'In vivo and in vitro functional study of the stem cell factor TBX3 65
How interacting pathways are regulated by miRNAs in breast cancer subtypes 64
Myosins and MyomiR Network in Patients with Obstructive Hypertrophic Cardiomyopathy 64
A rat mammary gland cancer cell with stem cell properties of self-renewal, multi-lineage differentiation and tumor sustainability 63
Chronic Gastrointestinal Disorders and miRNA-Associated Disease: An Up-to-Date 62
Molecular and Cellular Complexity of Glioma. Focus on Tumour Microenvironment and the Use of Molecular and Imaging Biomarkers to Overcome Treatment Resistance 62
Cell-cycle arrest in TrkA-expressing NIH3T3 cells involves nitric oxide synthase 61
Triple negative aggressive phenotype controlled by miR-135b and miR-365: new theranostics candidates 60
Urban Health Assessment Through a Planetary Health Perspective: Methods and First Results from the Rome NBFC Experiment 59
Radio-chemotherapy and metformin selectively modulate the heterogeneous landscape of glioma with ribosome biogenesis, long non coding RNA and immune-escape markers as major player 57
Radiogenomics, Breast Cancer Diagnosis and Characterization: Current Status and Future Directions 57
Non-Coding RNAs: New Biomarkers and Therapeutic Targets for Temporal Lobe Epilepsy 57
Identification of key miRNAs in prostate cancer progression based on miRNA-mRNA network construction 56
Characterization of cell cycle, inflammation, and oxidative stress signaling role in non-communicable diseases: Insights into genetic variants, microRNAs and pathways 56
Evaluation of Radiotherapy associated with Temozolomide plus Metformin in a GBM immunocompetent microenvironment 55
Isolation of Canine Mammary Cells With Stem Cell Properties and Tumour-Initiating Potential 54
Serum MicroRNAs as Predictors of Diagnosis and Drug-resistance in Temporal Lobe Epilepsy: A Preliminary Study 54
Diagnostic Circulating miRNAs in Sporadic Amyotrophic Lateral Sclerosis 53
Minor Allele Frequencies and Molecular Pathways Differences for SNPs Associated with Amyotrophic Lateral Sclerosis in Subjects Participating in the UKBB and 1000 Genomes Project 53
Integration of mRNA Expression Profile, Copy Number Alterations, and microRNA Expression Levels in Breast Cancer to Improve Grade Definition. 52
Secreted miR‐153 Controls Proliferation and Invasion of Higher Gleason Score Prostate Cancer 51
Distinct populations of tumor-initiating cells derived from a tumor generated by rat mammary cancer stem cells. 50
The properties of a mammary gland cancer stem cell. 49
Portrait of Tissue-Specific Coexpression Networks of Noncoding RNAs (miRNA and lncRNA) and mRNAs in Normal Tissues 49
The properties of a mammary gland cancer stem cell 49
CMA mediates resistance in breast cancer models. 49
MicroRNA involvement in Embryonic stem cell pluripotency maintenance and fate determination 48
A rat mammary gland cancer cell with stem cell properties of self-renewal and multilineage differentiation 48
A rat mammary gland cancer cell with stem cell properties of self-renewal and multi-lineage differentiation 47
Plasmatic and myocardial microRNA profiles in patients with Hypertrophic Cardiomyopathy 47
Evaluating [18F]FDG and [18F]FLT Radiotracers as Biomarkers of Response for Combined Therapy Outcome in Triple-Negative and Estrogen-Receptor-Positive Breast Cancer Models 46
Effects of liposome-entrapped annamycin in human breast cancer cells: Interference with cell cycle progression and induction of apoptosis 45
The role of microRNA in epithelial to mesenchymal transition. 45
Pathway-based classification of breast cancer subtypes 44
Identification of functionally related genes using data mining and data integration: a breast cancer case study 44
SpidermiR: An R/Bioconductor Package for Integrative Analysis with miRNA Data 43
A rat mammary gland cancer cell with stem cell properties of self-renewal and multi-lineage differentiation 41
Potential Role of miRNAs as Theranostic Biomarkers of Epilepsy 41
The potential of miRNAs for diagnosis, treatment and monitoring of breast cancer. 39
A protein interaction map identifies existing drugs targeting SARS-CoV-2 39
Identification and characterization of micro-RNA genes that control rat mammary cell differentiation. 38
Integrating genetics and epigenetics in breast cancer: biological insights, experimental, computational methods and therapeutic potential. 35
A rat cancer stem cell model system for studying tumor initiation at the single cell level 35
Functional study of Tbx3, the gene mutated in the Ulnar-Mammary Syndrome. 34
MicroRNAs as Biomarkers for Diagnosis, Prognosis and Theranostics in Prostate Cancer. 33
Pathway-based expression profile for breast cancer diagnoses. 32
Interpreting pathways to discover cancer driver genes with Moonlight. 32
Potential drugs against COVID-19 revealed by gene expression profile, molecular docking and molecular dynamic simulation 32
Potential drugs against COVID-19 revealed by Gene Expression Profile, Molecular Docking and Molecular Dynamic Simulation: Supplementary File.pptx 31
In-Silico Integration Approach to Identify a Key miRNA Regulating a Gene Network in Aggressive Prostate Cancer. 30
Moonlight: a tool for biological interpretation and driver genes discovery 30
In silico identification of drug target pathways in breast cancer subtypes using pathway cross-talk inhibition. 29
Integrative Analysis with Monte Carlo Cross-Validation Reveals miRNAs Regulating Pathways Cross-Talk in Aggressive Breast Cancer 28
The TBX3 gene, mutated in Ulnar-Mammary syndrome, promotes growth of mammary epithelial cells independently of ARF and p53. 28
Thiol-mediated protein retention in the endoplasmic reticulum: The role of ERp44 28
Theranostic biomarkers in hypertrophic cardiomyopathy: insights in a long road ahead 27
Dynamic retention of Ero1alpha and Ero1beta in endoplasmic reticulum by interactions with PDI and ERp44 27
Integration of multiple networks and pathways identifies cancer driver genes in pan-cancer analysis. 27
Dynamic retention of Ero1? and Ero1? in the endoplasmic reticulum by interactions with PDI and ERp44 26
In Silico Discovery of Candidate Drugs against Covid-19 26
TBX3, the gene mutated in ulnar-mammary syndrome, promotes growth of mammary epithelial cells via repression of p19ARF, independently of p53. 26
MicroRNA-567 dysregulation contributes to carcinogenesis of breast cancer, targeting tumor cell proliferation, and migration 26
MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer. 25
The C-terminal domain of yeast Ero1p mediates membrane localization and is essential for function 24
In vivo and in vitro functional study of Tbx3, the gene mutated in the Ulnar Mammary sindrome 24
Two conserved cysteine triads in human Ero1alpha cooperate for efficient disulfide bond formation in the endoplasmic reticulum. 24
In silico approach for the definition of radiomirnomic signatures for breast cancer differential diagnosis 23
ERdj5, an endoplasmic reticulum (ER)-resident protein containing DnaJ and thioredoxin domains, is expressed in secretory cells or following ER stress 23
Cellular responses of human bronchial epithelial cells following short-term exposure to oxidative particulate matter 21
A novel AMPK activator reduces glucose uptake and inhibits tumor progression in a mouse xenograft model of colorectal cancer 20
Microdissection and SAGE: combined tools for transcriptomic analysis of pure cell populations of mammary carcinoma 19
Effects of particulate air pollution exposure on lung-brain axis and related miRNAs modulation in mouse models 17
Theranostic biomarkers in hypertrophic cardiomyopathy: Insights in a long road ahead 17
Dynamic retention of Ero1alpha and Ero1beta in endoplasmic reticulum by interactions with PDI and ERp44 13
Exposome, oxidative stress and inflammation in persons with multiple sclerosis: the EXPOSITION study protocol 8
Maternal–fetal microRNA axis in congenital heart disease: implications for tetralogy of Fallot 7
SpidermiR: An R/bioconductor package for integrative analysis with miRNA data 4
Dynamic retention of Ero1alpha and Ero1beta in endoplasmic reticulum by interactions with PDI and ERp44 2
Totale 3.839
Categoria #
all - tutte 12.505
article - articoli 10.005
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.510


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202442 0 0 0 0 0 0 0 0 2 0 37 3
2024/20251.424 2 7 84 42 334 102 41 100 65 34 324 289
2025/20262.302 146 282 201 358 410 76 306 94 148 148 83 50
2026/202771 71 0 0 0 0 0 0 0 0 0 0 0
Totale 3.839